Table 1. Baseline characteristics (intent‐to‐treat population).
Paclitaxel, docetaxel, nab‐paclitaxel, or taxane (not otherwise specified).
Epirubicin, doxorubicin, mitoxantrone, or anthracycline (not otherwise specified).
Abbreviation: ECOG, Eastern Cooperative Oncology Group.